PIK3CA and neoplasm: Other studies that support these findings exist, in which treatment with different PI3K inhibitors (wortmannin, LY294002, IPI-145) quenched mouse and human NK cell cytotoxicity against tumor cells (120–122) while inhibition of a single p110 isoform did not have a profound effect.